Dyadic International Inc SEC filings DYAI
Dyadic International Inc has 540 filings in SEC EDGAR's recent list, going back to Jan 21, 2003. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 15, 2026 | — |
| 8-K |
Current report
Listing notice
|
Sep 25, 2026 | Sep 25, 2026 |
| EFFECT | Filing | Sep 18, 2026 | — |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| S-1 | Registration statement | Sep 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 17, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 14, 2026 | Aug 13, 2026 |
| 424B5 | Prospectus supplement | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Jul 24, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Other events
|
Jul 24, 2026 | Jul 24, 2026 |
| 144 | Notice of proposed sale | Jul 21, 2026 | — |
| 4 | Insider transaction | Jul 6, 2026 | Mar 8, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 6, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| DEFA14A | Additional proxy material | Jun 18, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 15, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2026 | May 28, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| DEF 14A | Proxy statement | May 12, 2026 | May 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 11, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 11, 2026 | — |
| PRE 14A | Preliminary proxy statement | May 1, 2026 | May 1, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 30, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 6, 2026 | Mar 6, 2026 |
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 29, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 29, 2025 | Dec 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 7, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Sep 17, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 16, 2025 | Sep 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 19, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 1, 2025 | Jul 30, 2025 |
| 424B5 | Prospectus supplement | Jul 31, 2025 | — |
| 424B5 | Prospectus supplement | Jul 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2025 | Jul 17, 2025 |
| 144 | Notice of proposed sale | Jul 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Listing notice
|
Jun 27, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | May 30, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 2, 2025 | May 29, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement
|
May 5, 2025 | May 1, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2025 | Apr 28, 2025 |
| EFFECT | Filing | Apr 2, 2025 | — |
| 144 | Notice of proposed sale | Mar 31, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2025 | — |
| S-3 | Shelf registration | Mar 26, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 26, 2025 | Mar 26, 2025 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 6, 2025 | — |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 2, 2025 |
| 144 | Notice of proposed sale | Dec 20, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 26, 2024 | Nov 16, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 8, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 2, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 2, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2024 | Jun 11, 2024 |
| 144 | Notice of proposed sale | Jun 6, 2024 | — |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| EFFECT | Filing | May 7, 2024 | — |
| CORRESP | Letter to the SEC | May 3, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2024 | — |
| S-3 | Shelf registration | Apr 24, 2024 | — |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Apr 11, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Apr 11, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Apr 11, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Mar 13, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 28, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Mar 11, 2024 | Mar 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 1, 2024 | — |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 6, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Agreement ended
|
Oct 6, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 19, 2023 | Sep 18, 2023 |
| EFFECT | Filing | Aug 25, 2023 | — |
| CORRESP | Letter to the SEC | Aug 23, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2023 | — |
| S-3 | Shelf registration | Aug 9, 2023 | — |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 15, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 12, 2023 | Apr 6, 2023 |
| 8-K |
Current report
Auditor change
|
Apr 10, 2023 | Apr 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 29, 2023 | Mar 28, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 14, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Auditor change
|
Feb 22, 2023 | Feb 16, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| 8-K |
Current report
Other events
|
Jan 24, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 23, 2023 | Jan 18, 2023 |
| 5 | Annual insider ownership | Jan 5, 2023 | Dec 31, 2022 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 5, 2023 | Jan 3, 2023 |
| 8-K |
Current report
Other events
|
Jan 4, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Oct 27, 2022 | Oct 27, 2022 |
| 4/A | Filing | Sep 20, 2022 | Jul 27, 2021 |
| 8-K |
Current report
Other events
|
Sep 13, 2022 | Sep 13, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 4 | Insider transaction | Jul 11, 2022 | Jul 7, 2022 |
| 4 | Insider transaction | Jun 14, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 14, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 14, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 14, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 14, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 14, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2022 | Jun 10, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
May 11, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2022 | Apr 22, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DYAI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jupiter, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1213809
- Former names
- CCP WORLDWIDE INC (until Nov 5, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.